INFUSION REACTION

Clinical trials for INFUSION REACTION explained in plain language.

Never miss a new study

Get alerted when new INFUSION REACTION trials appear

Sign up with your email to follow new studies for INFUSION REACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Allergy pill may shield cancer patients from dangerous treatment reactions

Symptom relief Completed

This study tested if adding montelukast (Singulair), a drug used for asthma and allergies, to standard pre-treatment medications could reduce severe infusion reactions in patients receiving monoclonal antibody treatments for blood cancers. The trial involved 40 adults with blood …

Matched conditions: INFUSION REACTION

Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Symptom relief

Last updated Mar 18, 2026 14:55 UTC

INFUSION REACTION

Get alerted when new INFUSION REACTION trials appear

Allergy pill may shield cancer patients from dangerous treatment reactions